Chapter 14
Cannabis Use and Psychosis
Book Editor(s):Dr Peter Phillips PhD, MSc, RMN, PGCAP, FHEA,
Dr Olive McKeown PhD, MSc, Dip N, CELTT, Cert Obst, RMN, RGN,
Tom Sandford BSc (Hons), Dip N, RGN, RMN,
Dr Peter Phillips PhD, MSc, RMN, PGCAP, FHEA
senior lecturer honorary lecturer member specialist
City University London, UK
Search for more papers by this authorDr Olive McKeown PhD, MSc, Dip N, CELTT, Cert Obst, RMN, RGN
visiting lecturer specialist lecturer practitioner senior lecturer
St George's University, London, UK
Search for more papers by this authorTom Sandford BSc (Hons), Dip N, RGN, RMN
executive director policy adviser regional director general manager Head member
Royal College of Nursing, London, UK
Search for more papers by this authorFirst published: 09 September 2009
Summary
This chapter contains sections titled:
-
Introduction
-
What is cannabis?
-
How is it used?
-
Legal issues
-
How it affects the user
-
Psychological effects
-
Physical effects
-
Safety issues
-
The links between cannabis and psychosis
-
Interventions for cannabis and psychosis
-
Conclusion
-
References
References
- Addington J, Addington D (2007) Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatrica Scandinavica 115 (4): 304–309.
- Advisory Council for Misuse of Drugs (ACMD) (2008) Cannabis: Classification and Public Health. London: Home Office. http://drugs.homeoffice.gov. uk/publication-search/acmd/acmd-cannabis-report-2008?view=Binary.
- Allebeck P, Adamsson C, Engstrom A, Rydberg U (1993) Cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm County. Acta Psychiatrica Scandinavica 88 (1): 21–24.
- Andreasson S, Allebeck P, Rydberg U (1987) Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County. Acta Psychiatrica Scandinavica 79 (5): 505–510.
- Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jorgensen P (2005) Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. The British Journal of Psychiatry: The Journal of Mental Science 187: 510–515.
- Arseneault L, Cannon M, Poulton R, et al. (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal 325 (7374): 1212–1213.
- Arseneault L, Cannon M, Witton J, Murray RM (2004) Causal association between cannabis and psychosis: examination of the evidence. The British Journal of Psychiatry: The Journal of Mental Science 184: 110–117.
- Baker A, Bucci S, Lewin TJ, et al. (2006) Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: randomised controlled trial. The British Journal of Psychiatry: The Journal of Mental Science 188: 439–448.
- Baker A, Lewin T, Reichler H, et al. (2002) Evaluation of a motivational interview for substance use within psychiatric in-patient services. Addiction 97 (10): 1329–1337.
- Barkus EJ, Stirling J, Hopkins RS, Lewis S (2006) Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psycho-pathology 39 (4): 175–178.
- Barnett JH, Werners U, Secher SM, et al. (2007) Substance use in a population-based clinic sample of people with first-episode psychosis. The British Journal of Psychiatry: The Journal of Mental Science 190: 515– 520.
- Barrowclough C, Haddock G, Tarrier N, et al. (2001) Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. The American Journal of Psychiatry 158 (10): 1706–1713.
- Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y (2006) A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry 63 (4): 426–432.
- Ben Amar M, Potvin S (2007) Cannabis and psychosis: what is the link? Journal of Psychoactive Drugs 39 (2): 131–142.
- Carey KB, Leontieva L, Dimmock J, Maisto SA, Batki SL (2007) Adapting motivational interventions for comorbid schizophrenia and alcohol use disorders. Clinical Psychology: Science and Practice 14: 39–57.
-
Condren RM, O'Connor J, Browne R (2001) Prevalence and patterns of substance misuse in schizophrenia: a catchment area case–control study. Psychiatric Bulletin 25: 17–20.
10.1192/pb.25.1.17 Google Scholar
- Cougnard A, Marcelis M, Myin-Germeys I, et al. (2007) Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model. Psychological Medicine 37 (4): 513–527.
- Department of Health (DH) (2006a) Cannabis Toolkit. http://www.csip.org. uk/national-programmes/national-programmes/national-insititute-for-mental-health-in-england/mental-health-and-cannabis.html.
- Department of Health (DH) (2006b) Dual Diagnosis in Mental Health Inpatient and Day Hospital Settings. Guidance on the Assessment And Management of Patients In Mental Health Inpatient and Day Hospital Settings Who Have Mental Ill-Health and Substance Use Problems. London: Department of Health. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH 062649 (30.10.2006).
- Degenhardt L, Tennant C, Gilmour S, et al. (2007) The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychological Medicine 37 (7): 927–934.
- Duke PJ, Pantelis C, McPhillips MA, Barnes TR (2001) Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London. The British Journal of Psychiatry: The Journal of Mental Science 179: 509–513.
- Edwards J, Elkins K, Hinton M, et al. (2006) Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatrica Scandinavica 114 (2): 109–117.
- EMCDDA Statistical Bulletin (2006) European Monitoring Centre for Drugs and Drug Addiction. Available at: http://stats06.emcdda.europa.eu/en/home-en.html.
- Gray R, Wykes T, Edmonds M, Leese M, Gournay K (2004) Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia: cluster randomised controlled trial. The British Journal of Psychiatry: The Journal of Mental Science 185: 157–162.
- Green B, Kavanagh DJ, Young RM (2004) Reasons for cannabis use in men with and without psychosis. Drug and Alcohol Review 23 (4): 445–453.
- Hambrecht M, Hafner H (2000) Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. The Australian and New Zealand Journal of Psychiatry 34 (3): 468–475.
- Hides L, Dawe S, Kavanagh DJ, Young RM (2006) Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study. The British Journal of Psychiatry: The Journal of Mental Science 189: 137–143.
- Kemp R, Harris A, Vurel E, Sitharthan T (2007) Stop using stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists 15 (6): 490–493.
- Kemp R, Hayward P, Applewhaite G, Everitt B, David A (1996) Compliance therapy in psychotic patients: randomised controlled trial. British Medical Journal 312 (7027): 345–349.
- Linszen DH, Dingemans PM, Lenior ME (1994) Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry 51 (4): 273–279.
- Martino S, Carroll KM, Nich C, Rounsaville BJ (2006) A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders. Addiction 101 (10): 1479–1492.
- McCambridge J, Strang J (2004) The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomized trial. Addiction 99 (1): 39–52.
- Menezes PR, Johnson S, Thornicroft G, et al. (1996) Drug and alcohol problems among individuals with severe mental illness in south London. The British Journal of Psychiatry: The Journal of Mental Science 168 (5): 612–619.
- Miettunen J, Tormanen S, Murray GK, et al. (2008) Association of cannabis use with prodromal symptoms of psychosis in adolescence. The British Journal of Psychiatry: The Journal of Mental Science 192 (6): 470–471.
- Miles H, Johnson S, Amponsah-Afuwape S, et al. (2003) Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder. Psychiatric Services 54 (4): 554–561.
- National Treatment Agency (NTA) (2003) Confidentiality and Information Sharing. http://www.nta.nhs.uk/publications/documents/nta confidentiality and info sharing 2003 dsp1.pdf.
- Olmstead TA, Sindelar JL, Easton CJ, Carroll KM (2007) The cost-effectiveness of four treatments for marijuana dependence. Addiction 102 (9): 1443–1453.
- Phillips P, Johnson S (2003) Drug and alcohol misuse among in-patients with psychotic illnesses in three inner London psychiatric units. Psychiatric Bulletin 27: 217–220.
- Rathbone J, Variend H, Mehta H (2008) Cannabis and schizophrenia. Cochrane Database of Systematic Reviews 3 (3): CD004837.
- Smit F, Bolier L, Cuijpers P (2004) Cannabis use and the risk of later schizophrenia: a review. Addiction 99 (4): 425–430.
- Soyka M, Albus M, Kathmann N, et al. (1993) Prevalence of alcohol and drug abuse in schizophrenic inpatients. European Archives of Psychiatry and Clinical Neuroscience 242 (6): 362–372.
- Talk to Frank (web-based information). Too Much Too Often. Guide to cutting down Cannabis. http://www.talktofrank.com/cannabis.aspx.
- van Os J, Bak M, Hanssen M, et al. (2002) Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology 156 (4): 319–327.
- van Winkel R, Henquet C, Rosa A, et al. (2008) Evidence that the COMT (Val158Met) polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 147B (1): 10–17.
- Weaver T, Rutter D, Madden P, et al. (2001) Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: prevalence and service needs in an inner London borough. Social Psychiatry and Psychiatric Epidemiology 36 (8): 399–406.
- Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G (2002) Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. British Medical Journal 325 (7374): 1199.
